Global medical development is undergoing a profound structural change in 2026, with health equity officially moving from a marginal social concept to a core research and practice direction of global medicine. For a long time, differences in regional medical resources, economic levels and population groups have led to serious unfair distribution of medical services, resulting in huge gaps in disease incidence, treatment effect and health life expectancy among different groups.
According to the latest research data from JAMA Network Open, racial, regional and economic health disparities are important factors restricting the overall improvement of global health levels. In low-income regions and remote areas, the shortage of high-end medical equipment, professional medical personnel and innovative drug resources leads to low early diagnosis rate and poor treatment effect of chronic diseases and tumors. Meanwhile, vulnerable groups such as the elderly, children and low-income populations are more likely to face the dilemma of difficult and expensive medical treatment.
In response to the global health equity dilemma, countries and international medical organizations have launched a series of targeted measures. Telemedicine and remote diagnosis technology break the geographical restrictions of medical resources, enabling remote areas to access high-quality expert diagnosis and treatment services. The universal promotion of grassroots medical training and standardized diagnosis and treatment guidelines improves the service capacity of primary medical institutions. In addition, the popularization of generic drugs and the centralized procurement of innovative drugs effectively reduce the medical burden of patients and narrow the treatment gap caused by economic differences.
In the future, health equity will run through the whole process of medical research, policy formulation and clinical service. Medical research will pay more attention to the disease characteristics and medical needs of vulnerable groups, and medical resource allocation will tend to be balanced and inclusive. The ultimate goal is to realize that all people can obtain equal, high-quality and affordable medical and health services, and comprehensively improve the global public health level.

